Stock listing

NASDAQ:ITOS Iteos Therapeutics Inc Stock

Follow Iteos Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ITOS

$10.15 USD

Close on Aug 29, 2025 · No longer trades

Jul 24, 2020 to last close -46.7% · weekly closes, Jul 24, 2020 – Aug 29, 2025
Lowest – highest close
$5.04 – $47.86 USDSince Jul 24, 2020 · lowest Apr 8, 2025 · highest Dec 28, 2021

Delisted NASDAQ:ITOS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ITOS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Iteos Therapeutics Inc on 6ix

Calls
3 calls with a replay · 3 with a transcript · latest Nov 10, 2021
Decks
8 decks · latest Jan 13, 2025

Events

CallWhenStatus
Iteos Therapeutics (ITOS) Q3 2021 Earnings CallWed, Nov 10, 2021 · 4:30 PM ETReplay
Iteos Therapeutics (ITOS) Q2 2021 Earnings CallThu, Aug 12, 2021 · 8:00 AM ETReplay
Iteos Therapeutics (ITOS) Q1 2021 Earnings CallThu, May 13, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
JPM HC Conference January 2025Conference29 slidesJan 13, 2025
ESMO 2024Conference20 slidesSep 16, 2024
Investor Presentation (January 2024)Investor deck27 slidesJan 10, 2024
Investor Presentation (January 2023)Investor deck18 slidesJan 9, 2023
Investor Presentation (January 2022)Investor deck12 slidesJan 11, 2022
Corporate Update (April 2021)Corporate update19 slidesApr 12, 2021
Investor Presentation (January 2021)Investor deck16 slidesJan 11, 2021
Investor Presentation (November 2020)Investor deck27 slidesNov 12, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rajeev M Shah
Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past)
Director · Jun 9, 2022 – Jun 9, 2022 · Past
David L. Hallal
Other companies: Scholar Rock Holding Corporation (Chairman and Chief Executive Officer · Since at least Jun 27, 2024); Kalaris Therapeutics, Inc. (Director · Since at least Jun 6, 2024); Seer, Inc. (Director · Jun 12, 2024 – Jun 12, 2024 · Past)
Director · Since at least Jun 11, 2024
Aaron I Davis
Other companies: Tango Therapeutics, Inc. (Director · Jun 8, 2022 – Aug 11, 2023 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past)
Director · Jul 23, 2020 – Jun 11, 2024 · Past
Matthew Gall
Other companies: Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Apr 15, 2026); Kalaris Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 3, 2025)
Chief Financial Officer · Since at least Jul 23, 2020
David FeltquateChief Medical Officer · Since at least Jul 31, 2024
David K LeeDirector · Since at least Dec 5, 2023
Joanne Jenkins LagerChief Medical Officer · Jul 23, 2020 – Mar 9, 2023 · Past
Yvonne McGrathChief Scientific Officer · Since at least Mar 1, 2021

Open People

Log in to ask 6ix AI your own questions about Iteos Therapeutics Inc.